Akt and c-Myc induce stem-cell markers in mature primary p53⁻/⁻ astrocytes and render these cells gliomagenic in the brain of immunocompetent mice

PLoS One. 2013;8(2):e56691. doi: 10.1371/journal.pone.0056691. Epub 2013 Feb 12.

Abstract

Astrocytomas and their most malignant variant glioblastoma multiforme (GBM) represent the vast majority of primary brain tumors. Despite the current progress in neurosurgery, radiation therapy and chemotherapy, most astrocytomas remain fatal disorders. Although brain tumor biology is a matter of intense research, the cell-of-origin and the complete astrocytoma-inducing signaling pathway remain unknown. To further identify the mechanisms leading to gliomagenesis, we transduced primary astrocytes on a p53(-/-) background with c-Myc, constitutively active myr-Akt or both, myr-Akt and c-Myc. Transduced astrocytes showed oncogene-specific alterations of morphology, proliferation and differentiation. Following prolonged periods of cultivation, oncogene-transduced astrocytes expressed several stem-cell markers. Furthermore, astrocytes coexpressing c-Myc and Akt were tumorigenic when implanted into the brain of immunocompetent C57BL/6 mice. Our results reveal that the loss of p53 combined with oncogene overexpression in mature astrocytes simulates pivotal features of glioma pathogenesis, providing a good model for assessing the development of secondary glioblastomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Astrocytes / pathology*
  • Biomarkers / metabolism
  • Brain / immunology
  • Brain / metabolism
  • Brain / pathology*
  • Cell Differentiation
  • Cell Proliferation
  • Cell Transformation, Neoplastic
  • Glioma / pathology*
  • Humans
  • Immunocompetence*
  • Mice
  • Mice, Inbred C57BL
  • Neoplastic Stem Cells / metabolism
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Proto-Oncogene Proteins c-myc / metabolism*
  • Tumor Suppressor Protein p53 / deficiency*

Substances

  • Biomarkers
  • MYC protein, human
  • Proto-Oncogene Proteins c-myc
  • Tumor Suppressor Protein p53
  • Proto-Oncogene Proteins c-akt

Grants and funding

This study was funded by an in-house grant according to the cooperation agreement between the University Hospital (UKGM) and the University of Marburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.